Rain Therapeutics Inc. (RAIN:NASDAQ) shot up at $3.44, a gain of 32.8%. On Thu, Jun 23, 2022, RAIN:NASDAQ hit a New 2-Week High of $3.44. The stock got featured on our News Catalysts scanner on Sun, Jun 05, 2022 at 09:16 AM in the 'INSIDER' category. From Fri, Jun 10, 2022, the stock recorded 75.00% Up Days and 44.44% Green Days
The stock spiked on Thu, Jun 23, 2022 at $4.39 with a volume of 4M+.
About Rain Therapeutics Inc. (RAIN:NASDAQ)
Rain Therapeutics Inc is a clinical-stage precision oncology company developing therapies that target oncogenic drivers for which they are able to genetically select patients they believe will most...
Top 10 Gainers:
- Fujian Blue Hat Interactive Entertainment Technology Ltd. (BHAT:NASDAQ), 263.03%
- RISE Education Cayman Ltd (REDU:NASDAQ), 138.46%
- F-star Therapeutics Inc. (FSTX:NASDAQ), 59.8%
- TDH Holdings, Inc. (PETZ:NASDAQ), 54.74%
- Vroom Inc. (VRM:NASDAQ), 36.44%
- Rain Therapeutics Inc. (RAIN:NASDAQ), 32.82%
- Molecular Data Inc. (MKD:NASDAQ), 32.18%
- Cardiff Oncology Inc. (CRDF:NASDAQ), 31.61%
- 22nd Century Group Inc (XXII:NASDAQ), 31.12%
- 9 Meters Biopharma, Inc. (NMTR:NASDAQ), 31.11%